Position in INVA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$37,745,858
+$7,376,993 QoQ
Shares Held
1,619,994
+6.6% QoQ
Ownership
2.19%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 84.65914071286684.ToString("F0")%
Shared 0.ToString("F0")%
None 15.340859287133163.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Derivatives in INVA
reported options exposure · as of Jun 30, 2021CallValue
$332,568
CallShares
24,800
PutValue
$332,568
PutShares
24,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. INVA ranks #57 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in INVA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,745,858 | 1,619,994 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $30,368,865 | 1,519,203 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,947,381 | 1,476,569 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $31,044,049 | 1,545,249 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $25,260,381 | 1,393,292 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $18,458,038 | 1,063,864 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $21,792,818 | 1,128,577 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,094,389 | 1,042,341 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $13,939,491 | 914,665 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,784,968 | 797,068 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,356,925 | 797,300 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,944,100 | 781,155 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,939,258 | 705,712 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,850,880 | 667,991 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $7,851,470 | 676,268 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $28,268,688 | 1,915,223 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $61,251,957 | 3,165,476 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $41,034,402 | 2,378,806 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $35,265,584 | 2,110,448 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $332,568 | 24,800 | Call | Defined | 2021-09-13 | |
| 2021-06-30 | $24,014,452 | 1,790,787 | Shares | Defined | 2021-09-13 | |
| 2021-06-30 | $332,568 | 24,800 | Put | Defined | 2021-09-13 | |
| 2021-03-31 | $18,182,950 | 1,521,586 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $17,847,780 | 1,440,499 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $14,510,607 | 1,388,575 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $26,548,870 | 1,899,061 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $19,604,436 | 1,667,044 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||